Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Diabetologia |
| Sider (fra-til) | 748 |
| ISSN | 0012-186X |
| Status | Udgivet - 2009 |
| Begivenhed | Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial - Varighed: 29 nov. 2010 → … |
Konference
| Konference | Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial |
|---|---|
| Periode | 29/11/2010 → … |
Bibliografisk note
JSEPSuppl. 1
Udgivelsesdato: 2009
Volumne: 52
ID: 21544857